Skip to main content
VCbacked
Log inGet Started

Link Cell Therapies

San Francisco, United States

Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.

$60.0M raised
Dec 2025
Series A
BiotechnologyLife ScienceMedical

Top Investors

Wing Venture CapitalSamsara BioCapitalBristol-Myers SquibbSherpa Healthcare PartnersJohnson & Johnson Innovation

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Link Cell Therapies

How much funding has Link Cell Therapies raised?
Link Cell Therapies has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Who are Link Cell Therapies's investors?
Link Cell Therapies's investors include Wing Venture Capital, Samsara BioCapital, Bristol-Myers Squibb, Sherpa Healthcare Partners, Johnson & Johnson Innovation.
Where is Link Cell Therapies headquartered?
Link Cell Therapies is headquartered in San Francisco, United States.
What does Link Cell Therapies do?
Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.
What stage is Link Cell Therapies at?
Link Cell Therapies is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Link Cell Therapies — Funding & Investors." VCBacked, December 15, 2025, https://www.vcbacked.co/company/link-cell-therapies. Accessed June 17, 2026.
APA
VCBacked. (2025). Link Cell Therapies — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/link-cell-therapies
Wikipedia (cite web)
{{cite web |title=Link Cell Therapies — Funding & Investors |url=https://www.vcbacked.co/company/link-cell-therapies |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong